Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Feb 17, 2020 1:58 AM EST Latest News February 10, 2020 U.S. FDA Grants Priority Review for Kite’s KTE-X19 Biologics License Application (BLA) in Relapsed or Refractory Mantle Cell Lymphoma February 4, 2020 Gilead Sciences Announces 8 Percent Increase In First Quarter 2020 Dividend February 4, 2020 Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results View All Events Feb 4, 2020 at 4:30 PM EST Fourth Quarter 2019 Gilead Sciences Earnings Conference Call Jan 13, 2020 at 9:30 AM PST Gilead Sciences at the 38th Annual J.P. Morgan Healthcare Conference Oct 24, 2019 at 4:30 PM EDT Third Quarter 2019 Gilead Sciences Earnings Conference Call View All
